Australia's PM-elect names health portfolio, but with a surprise

16 September 2013

As has been largely expected, Australia’s Prime Minister-elect Tony Abbott has this morning appointed former Shadow Minister for Health & Aging Peter Dutton to lead the Health portfolio (The Pharma Letter September 9) but surprised by dropping the role of parliamentary secretary, nine days after the coalition's election win over Labor. Deputy Leader in the Senate Fiona Nash has been named Assistant Health Minister.

Medicines Australia today (September 16) congratulated the Abbott Coalition government on being elected and welcomed the incoming ministers in the new government, including the appointment of Ian Macfarlane as Minister for Industry, with the trade group’s chief executive Brendan Shaw saying: “We look forward to working with him and his team on the important issues facing the Australian medicines industry.

He continued: “With over four years as Shadow Health Minister, Mr Dutton understands how the business model of this industry operates and the important role we play in delivering medicines to Australian patients. Mr Macfarlane has also worked well previously with the industry as Industry Minister under the Howard government. He understands the industry’s issues and we look forward to renewing our working relationship going forward.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical